Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells. - Wikidata - awgldk - TriplyDB

Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells.

Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells.

http://www.wikidata.org/entity/Q34485147

about

Immune regulation of bone metastasis Myeloid-derived suppressor cells as therapeutic target in hematological malignancies Immunotherapy strategies for multiple myeloma: the present and the future Dissecting the role of bone marrow stromal cells on bone metastases.Osteoclasts: more than 'bone eaters'.Human osteoclasts are inducible immunosuppressive cells in response to T cell-derived IFN-γ and CD40 ligand in vitro Bone-immune cell crosstalk: bone diseases.Pathogenesis beyond the cancer clone(s) in multiple myeloma.Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells.Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities Osteoclasts-Key Players in Skeletal Health and Disease.Myeloid-derived suppressor cells as osteoclast progenitors: a novel target for controlling osteolytic bone metastasis Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma.Location of tumor affects local and distant immune cell type and number Contributions of the host microenvironment to cancer-induced bone disease.Signaling between tumor cells and the host bone marrow microenvironment.Integrating new discoveries into the "vicious cycle" paradigm of prostate to bone metastases.Bone and the innate immune system.Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche.Myeloid-derived suppressor cells: their role in the pathophysiology of hematologic malignancies and potential as therapeutic targets.Targeting the bone marrow microenvironment in multiple myeloma.Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities.The Impact of Immune System in Regulating Bone Metastasis Formation by Osteotropic Tumors.Ex Vivo and In Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents Targeting the Bone Marrow Microenvironment.One microenvironment does not fit all: heterogeneity beyond cancer cells.Bone marrow myeloid cells in regulation of multiple myeloma progression.Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC)Phenotype and Function of Myeloid-Derived Suppressor Cells Induced by Porphyromonas gingivalis Infection.Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication.Myeloid-derived suppressor cells as a novel target for the control of osteolytic bone disease.Emerging Roles of Osteoclasts in the Modulation of Bone Microenvironment and Immune Suppression in Multiple Myeloma Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma.Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs.Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma.Hierarchical Involvement of Myeloid-Derived Suppressor Cells and Monocytes Expressing Latency-Associated Peptide in Plasma Cell Dyscrasias.Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1

P2860

Q27005871-BAFF62B6-8B08-4875-9CF9-87CF783BAAA4 Q27010234-3B137A21-582C-4A9F-AC43-CA68F52C4DDC Q27021939-E5F85F57-C5D8-4C5C-8E92-D783F6CE1865 Q33904588-69875F9B-68DC-4D30-845B-491CC34DBB3B Q33993757-789BBE3C-ABC1-41BD-A612-A6E68628E887 Q34674972-D53138D7-B06D-4011-888F-574387CBB203 Q35592362-57B049D6-386A-4FBE-84D6-FD4D48E2774A Q35607266-2E9E31BD-A1DE-428D-A473-66CA0CF5255B Q35833055-A40157D5-024E-4D39-8460-448A2679E895 Q36447553-7AD0F7F2-AA74-4572-BB49-201AA973F3F0 Q37036135-D43FBB72-4130-4321-A95F-DBAF87EB15C1 Q37067495-9B046F04-6AA7-41EC-A7B8-D175D9E946C7 Q37437357-07DDE68F-9B72-4772-90CF-39A418C82FFC Q37660747-A83C0675-2933-47C4-A0FD-3C5EF13E898C Q37663962-401809FB-DDC8-475D-8EA6-E7CAFB870FE0 Q38138849-A569D82A-3EF9-40A9-9D3D-DBCB7DE41E70 Q38177689-B74121AF-7AFB-4359-8756-EEEADD0F276E Q38185586-CFB2DD6A-9B7A-40C5-AC1B-E2FD33ECED24 Q38232436-8299EE2C-358F-4F94-A21D-627898F8EC1F Q38269370-39442C59-11E5-4908-ACB1-576901384169 Q38289041-C16C5952-9A81-4118-982B-A98AFFDB5E46 Q38299932-98A82D81-289A-4817-9AB2-60557C9322DE Q38524842-66B81A19-07F6-463B-A618-56091332744A Q38805822-11110ABB-33FD-47A3-8347-BC00A001077C Q38970585-5F01A277-01CF-4FCA-846F-F7872739930C Q39011826-B30EAFB4-4A14-40BA-9D67-391477BFC013 Q39220773-BE84934A-C2EA-494D-8CD6-B3202272B689 Q39928926-76C6E0CF-C2FE-42C6-A7BC-019BFEA5D06C Q40202758-36B4EB60-BC8C-4A24-A233-DF5B146C28BD Q41168758-629C8C0F-6BDD-459E-802D-F13A86E32D34 Q41219325-AE6A6159-9E37-4FF4-BC41-B8DFBFF8AD7B Q41370609-3A1CB5A0-43DD-4492-8C15-2F3692250FDA Q47326177-78C7AB57-305E-4ABF-A7FF-78F0BBDBB46D Q49830211-5BE0D1D6-CB71-4648-B76C-5AF58A8E7A20 Q50621370-D18E399D-8BD8-4EBC-AD21-158E2CE18DA3 Q52723606-91641DA8-B725-4C1F-BE09-AEF3AEE7EB02 Q58790080-94F1B464-4E3A-47D4-8100-D46AE2A6743F

P2860

Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells.

http://www.wikidata.org/entity/Q34485147

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Osteoclasts in multiple myelom ...... loid-derived suppressor cells.

@ast

Osteoclasts in multiple myelom ...... loid-derived suppressor cells.

@en

Osteoclasts in multiple myelom ...... loid-derived suppressor cells.

@nl

type

label

Osteoclasts in multiple myelom ...... loid-derived suppressor cells.

@ast

Osteoclasts in multiple myelom ...... loid-derived suppressor cells.

@en

Osteoclasts in multiple myelom ...... loid-derived suppressor cells.

@nl

prefLabel

Osteoclasts in multiple myelom ...... loid-derived suppressor cells.

@ast

Osteoclasts in multiple myelom ...... loid-derived suppressor cells.

@en

Osteoclasts in multiple myelom ...... loid-derived suppressor cells.

@nl

P1433

Q34485147-725C8B6E-E677-4347-8E04-4CCD87C5B3B0

P1476

Q34485147-CADF5A9E-83CA-404D-A616-3A0001E3F728

P2093

Q34485147-5CC9E26C-1EE2-49D1-8007-8B0C7242800E

Q34485147-79976C87-6C42-4438-BA13-D28988BEE512

Q34485147-8A792F9F-A10A-4AEA-9787-C5D44841E7FA

Q34485147-8C33C981-5EAB-46C1-A27C-8B8D7EAEA138

Q34485147-971963FA-212B-46AE-BFB8-F1C82B486568

Q34485147-F6B8A6C2-2B05-483E-87DB-10C95EA7BBBC

P2860

Q34485147-0369F628-98DE-45E2-9D09-A7680D9C867D

Q34485147-0C81575F-82C7-4B93-8124-904C3A631968

Q34485147-0E2902FC-8764-40E1-BFA0-546966F947CE

Q34485147-1D846786-31B6-45EF-BE19-871DD0B63AA6

Q34485147-1DEBD0CF-70A6-45E5-AEF8-EBBEE9D8BCA1

Q34485147-238BEA3D-7100-4F81-BDAF-1C250896B789

Q34485147-323A7119-12DB-4444-BD07-816313A7CFE4

Q34485147-35879FF4-B098-4F70-BF0D-BEE229821A3F

Q34485147-39E3C606-ABBC-4D53-9B3B-DC3E5A451BA2

Q34485147-41899A7F-4938-40E0-8DF9-14B3215D3BE4

P304

Q34485147-C3E233BC-064E-415A-B5A3-3388E62178EB

P31

Q34485147-3ADE8E02-E228-45C0-9A41-055ABDA3FD45

P356

Q34485147-3D839AC9-02F0-4CB3-95A7-46E3038C9E28

P407

Q34485147-312B9EA0-0DD0-482D-B549-C7953E3AEDA3

P433

Q34485147-AE7DEE76-E23F-4F1A-88FC-129C9FA042A5

P478

Q34485147-0923BDCE-E9D5-436F-9E9F-11760C8C2DCC

P50

Q34485147-95B333D5-83A8-44A3-B8B3-7F14114FF5D6

P577

Q34485147-C42603DA-5D45-479E-BB01-444B60E2F5B7

P5875

Q34485147-07597D51-35EB-4AD8-BBAF-B311296D7B58

P698

Q34485147-BBBC9240-19D0-4F44-AC17-FB300883A061

P932

Q34485147-27A6C10E-5107-4F61-B338-929242BB001E

P356

JOURNAL.PONE.0048871

P1433

P1476

Osteoclasts in multiple myelom ...... loid-derived suppressor cells.

@en

P2093

Gregory R Mundy

http://www.w3.org/2001/XMLSchema#string

James R Edwards

http://www.w3.org/2001/XMLSchema#string

Jianghong Zhang

http://www.w3.org/2001/XMLSchema#string

Junling Zhuang

http://www.w3.org/2001/XMLSchema#string

Seint T Lwin

http://www.w3.org/2001/XMLSchema#string

Xiangli Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.

Protein prenylation: molecular mechanisms and functional consequences

Transforming growth factor-beta in osteolytic breast cancer bone metastases.

Molecular mechanisms of breast cancer metastases to bone.

HERG K+ channels activation during beta(1) integrin-mediated adhesion to fibronectin induces an up-regulation of alpha(v)beta(3) integrin in the preosteoclastic leukemia cell line FLG 29.1.

Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine.

Multiple myeloma and related disorders. Lessons from an animal model.

Molecular mechanisms of action of bisphosphonates.

Antitumor activity of thalidomide in refractory multiple myeloma.

Preparing the "soil": the premetastatic niche.

P304

e48871

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0048871

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Claire M Edwards

P577

2012-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233746272

http://www.w3.org/2001/XMLSchema#string

P698

23173040

http://www.w3.org/2001/XMLSchema#string

P932

3500251

http://www.w3.org/2001/XMLSchema#string